Testicular Cancer VL

Comparing Cost-Effectiveness of Surgery, Radiation, and Chemo for Seminoma - Daniel Joyce

Details
Ruchika Talwar interviews Daniel Joyce about his journey into cost-effectiveness studies, particularly in testicular cancer. Initially skeptical, Dr. Joyce now sees these studies as crucial for interpreting clinical trial data in real-world contexts. He discusses his analysis of the SEMS trial, focusing on small-volume stage two seminoma, where RPLND emerged as the most cost-effective option compa...

Testicular Cancer Survivors Find Community and Healing Through Foundation and Patient Summit - Connor O'Leary & Charles Freeman McCluskey

Details
Zach Klaassen hosts a discussion with Connor O'Leary and Freeman McClusky, both testicular cancer survivors. They delve into the history and mission of Testicular Cancer Foundation (TCF), emphasizing its focus on education, awareness, and support since its inception in 2009. The conversation highlights the importance of community and brotherhood among survivors, with TCF playing a pivotal role in...

Detecting Early Testicular Cancer Relapse with Plasma MicroRNA Analysis - Lucia Nappi

Details
Zach Klaassen interviews Lucia Nappi about her research on the role of microRNAs in early-stage testicular cancer. MicroRNAs are small RNA fragments crucial for the regulation of oncogenes and tumor suppressors, with certain microRNAs notably overexpressed in testicular cancer. Dr. Nappi's team analyzed the microRNA-371 in plasma samples from stage I testicular cancer patients, finding that patien...

Hospital Anxiety and Depression Scale (HADS) Score Trends Among Testicular Cancer Survivors: a Longitudinal Study - Khalid Alkhatib

Details
Zach Klaassen hosts Khalid Alkhatib to discuss the mental health of testicular cancer patients. Dr. Alkhatib shares findings from his study, explaining that the disease impacts a younger demographic, making these patients more susceptible to anxiety and depression. The research revealed that the patients' anxiety and depression levels did not improve over time after active treatment, contrary to t...

Longer-Term Outcomes of Patients with Testicular Cancer: Late Relapses and Toxicities - Sia Daneshmand

Details
In this conversation with Alicia Morgans, MD, MPH, Siamak (Sia) Daneshmand discusses long-term follow-up of testicular cancer patients, a topic of interest to many navigating testicular cancer survivorship. Dr. Daneshmand provided an oral abstract discussion during the 2021 ASCO annual meeting highlighting two abstracts Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in...

Results From the IGCCCG Update Consortium in Metastatic Seminoma And Nonseminomatous Germ Cell Tumors – Silke Gillessen

Details
Silke Gillessen highlights the International Germ Cell Cancer Collaborative Group (IGCCCG) update model for both seminoma and non-seminoma patients highlighting two recently published articles in the Journal of Clinical Oncology, titled "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium" and "Survival and New Prognosticat...

Clinical Trials and Developments in Testicular Cancer - Darren Feldman

Details
Darren Feldman, MD, and Charles Ryan, MD, discuss multiple topics in this conversation on testicular germ cell tumors ranging from risk factors, developments in treatment, and the global TIGER study. There is limited data for the association of testis cancer with hereditary cancer genes. In this conversation, Daren Feldman highlights developments in treatment for testicular cancer including the in...

Testicular Cancer Survivorship & Advocacy - Scott Petinga

Details
Scott Petinga, a testicular cancer survivor, patient advocate, and entrepreneur, joins Charles Ryan, MD, to provide an update on his work in the field of testicular cancer advocacy. Scott Petinga shares research advances he is a part of at USC as well as different patient resource avenues like social media groups and online forums for newly diagnosed patients and testicular cancer survivors. Biogr...

Survivorship in Testicular Cancer - Mary Dunn

Details
The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...

Surgery In Early Metastatic Seminoma - Siamak Daneshmand

Details
The management of stage 2A seminoma has been consistent over the past several years, consisting of either radiotherapy or primary chemotherapy. Cure rates with these approaches are excellent but are also associated with many life years of potential cumulative toxicities. At the 2021 GU ASCO meeting, Dr. Siamak Daneshmand presented a phase 2 study in stage two seminoma, the Surgery In Early Metasta...